Roberto Freilone
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 26
- Genetics 16
- Chronic Lymphocytic Leukemia Research 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Umberto Vitolo (23 shared papers)Barbara Botto (21 shared papers)M Bertini (10 shared papers)L Resegotti (8 shared papers)Lorella Orsucci (14 shared papers)Alessandro Levis (8 shared papers)Ernesta Audisio (13 shared papers)Domenico Novero (7 shared papers)
- Journals
- Blood (9 papers)Cancers (5 papers)Journal of Clinical Oncology (3 papers)Annals of Hematology (3 papers)Annals of Oncology (3 papers)
- Partner nations
- ItalyGermanyUnited States
In The Last Decade
Roberto Freilone
44 papers receiving 607 citations
Peers
Comparison fields: 5 of 43
- Pathology and Forensic Medicine 392
- Genetics 172
- Oncology 257
- Neurology 114
- Hematology 87
Countries citing papers authored by Roberto Freilone
This map shows the geographic impact of Roberto Freilone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Freilone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Freilone more than expected).
Fields of papers citing papers by Roberto Freilone
This network shows the impact of papers produced by Roberto Freilone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Freilone. The network helps show where Roberto Freilone may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Freilone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 79 | |
| 2 | 1997 | 52 | |
| 3 | 1994 | 51 | |
| 4 | 1996 | 50 | |
| 5 | 2009 | 49 | |
| 6 | Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients. | 1997 | 35 |
| 7 | 2012 | 32 | |
| 8 | 1996 | 32 | |
| 9 | 2022 | 30 | |
| 10 | 2023 | 20 | |
| 11 | 2016 | 16 | |
| 12 | 2011 | 15 | |
| 13 | Mantle cell lymphoma: a retrospective study on 27 patients. Clinical features and natural history. | 1998 | 14 |
| 14 | 2012 | 12 | |
| 15 | 2021 | 12 | |
| 16 | Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin). | 1997 | 12 |
| 17 | 1996 | 9 | |
| 18 | 2023 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2010 | 7 |
About Roberto Freilone
Roberto Freilone is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Neurology, having authored 47 papers that have together received 612 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (26 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Myeloid Leukemia Research (8 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (392 citations), Genetics (172 citations), Oncology (257 citations), Neurology (114 citations) and Hematology (87 citations). Roberto Freilone has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Umberto Vitolo, Barbara Botto, M Bertini, L Resegotti, Lorella Orsucci, Alessandro Levis, Ernesta Audisio, Domenico Novero, Gianluca Gaïdano and Giorgio Palestro. Their work appears in journals such as Blood, Cancers, Journal of Clinical Oncology, Annals of Hematology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.